53 related articles for article (PubMed ID: 21501330)
1. Fourteen-year-old girl with recurrent luteal-phase-dependent episodes of high fever.
Yamasaki H; Oki T; Iwamoto I; Douchi T
J Obstet Gynaecol Res; 2011 Aug; 37(8):1166-8. PubMed ID: 21501330
[TBL] [Abstract][Full Text] [Related]
2. Recurrent fever associated with progesterone action and persistently elevated serum levels of immunoreactive tumor necrosis factor-alpha and interleukin-6.
Rutanen EM; Teppo AM; Stenman UH; Tiitinen A; Fyhrquist F; Ylikorkala O
J Clin Endocrinol Metab; 1993 Jun; 76(6):1594-8. PubMed ID: 7684743
[TBL] [Abstract][Full Text] [Related]
3. Atypical estradiol secretion and ovulation patterns caused by luteal out-of-phase (LOOP) events underlying irregular ovulatory menstrual cycles in the menopausal transition.
Hale GE; Hughes CL; Burger HG; Robertson DM; Fraser IS
Menopause; 2009; 16(1):50-9. PubMed ID: 18978637
[TBL] [Abstract][Full Text] [Related]
4. Effects of the natural and artificial menstrual cycle on the production of osteoprotegerin and the bone resorptive cytokines IL-1beta and IL-6.
Abrahamsen B; Stilgren LS; Rettmer E; Bonnevie-Nielsen V; Beck-Nielsen H
Calcif Tissue Int; 2003 Jan; 72(1):18-23. PubMed ID: 12384814
[TBL] [Abstract][Full Text] [Related]
5. Effects of gonadotropin-releasing hormone agonists and antagonists on luteal function.
DiLuigi AJ; Nulsen JC
Curr Opin Obstet Gynecol; 2007 Jun; 19(3):258-65. PubMed ID: 17495643
[TBL] [Abstract][Full Text] [Related]
6. Further characterization of the luteal phase inadequacy after gonadotrophin-releasing hormone agonist-induced ovulation in gonadotrophin-stimulated cycles.
Balasch J; Fábregues F; Tur R; Creus M; Casamitjana R; Peñarrubia J; Barri PN; Vanrell JA
Hum Reprod; 1995 Jun; 10(6):1377-81. PubMed ID: 7593500
[TBL] [Abstract][Full Text] [Related]
7. Accelerated endometrial maturation in the luteal phase of cycles utilizing controlled ovarian hyperstimulation: impact of gonadotropin-releasing hormone agonists versus antagonists.
Saadat P; Boostanfar R; Slater CC; Tourgeman DE; Stanczyk FZ; Paulson RJ
Fertil Steril; 2004 Jul; 82(1):167-71. PubMed ID: 15237007
[TBL] [Abstract][Full Text] [Related]
8. Impact of gender and menstrual cycle phase on plasma cytokine concentrations.
O'Brien SM; Fitzgerald P; Scully P; Landers A; Scott LV; Dinan TG
Neuroimmunomodulation; 2007; 14(2):84-90. PubMed ID: 17713355
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of low dose hCG for luteal support after triggering ovulation with a GnRH agonist in cases of polyfollicular development.
Krause BT; Ohlinger R
Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):87-92. PubMed ID: 16377065
[TBL] [Abstract][Full Text] [Related]
10. Increased tumor necrosis factor-alpha in whole blood during the luteal phase of ovulatory cycles.
Amory JH; Lawler R; Hitti J
J Reprod Med; 2004 Aug; 49(8):678-82. PubMed ID: 15457859
[TBL] [Abstract][Full Text] [Related]
11. Low-dose human chorionic gonadotropin versus estradiol/progesterone luteal phase support in gonadotropin-releasing hormone agonist-triggered assisted reproductive technique cycles: understanding a new approach.
Garcia-Velasco JA; Motta L; López A; Mayoral M; Cerrillo M; Pacheco A
Fertil Steril; 2010 Dec; 94(7):2820-3. PubMed ID: 20673892
[TBL] [Abstract][Full Text] [Related]
12. Alcohol consumption attenuates febrile responses to lipopolysaccharide and interleukin-1 beta in male rats.
Taylor AN; Tio DL; Heng NS; Yirmiya R
Alcohol Clin Exp Res; 2002 Jan; 26(1):44-52. PubMed ID: 11821653
[TBL] [Abstract][Full Text] [Related]
13. Luteal phase estradiol and pregnancy outcome in gonadotropin releasing hormone agonist/human menopausal gonadotropin-treated gamete intrafallopian transfer cycles.
Molo MW; Rawlins RG; Binor Z; Kelly M; Radwanska E
J Reprod Med; 1995 Jun; 40(6):418-22. PubMed ID: 7650652
[TBL] [Abstract][Full Text] [Related]
14. Pyrogenic cytokines did not mediate a stress interview-induced hyperthermic response in a patient with psychogenic fever: a case report.
Hiramoto T; Oka T; Yoshihara K; Kubo C
Psychosom Med; 2009 Nov; 71(9):932-6. PubMed ID: 19875636
[TBL] [Abstract][Full Text] [Related]
15. GnRH agonist as novel luteal support: results of a randomized, parallel group, feasibility study using intranasal administration of buserelin.
Pirard C; Donnez J; Loumaye E
Hum Reprod; 2005 Jul; 20(7):1798-804. PubMed ID: 15890740
[TBL] [Abstract][Full Text] [Related]
16. Ovarian hyperstimulation syndrome prevention strategies: Luteal support strategies to optimize pregnancy success in cycles with gonadotropin-releasing hormone agonist ovulatory trigger.
Engmann L; Benadiva C
Semin Reprod Med; 2010 Nov; 28(6):506-12. PubMed ID: 21082510
[TBL] [Abstract][Full Text] [Related]
17. Ovarian hyperresponse to luteal phase GnRH-agonist administration.
Depenbusch M; Diedrich K; Griesinger G
Arch Gynecol Obstet; 2010 Jun; 281(6):1071-2. PubMed ID: 19960348
[TBL] [Abstract][Full Text] [Related]
18. Serum levels of soluble vascular cell adhesion molecule-1, tumor necrosis factor-alpha, and interleukin-6 in in vitro fertilization cycles.
Souter I; Huang A; Martinez-Maza O; Breen EC; Decherney AH; Chaudhuri G; Nathan L
Fertil Steril; 2009 May; 91(5 Suppl):2012-9. PubMed ID: 18778820
[TBL] [Abstract][Full Text] [Related]
19. Induction of circulating monocyte chemoattractant protein-1 in women with gonadotropin-releasing hormone agonist.
Matsui S; Yasui T; Uemura H; Yamamoto S; Matsuzaki T; Tsuchiya N; Yuzurihara M; Kase Y; Irahara M
J Reprod Immunol; 2011 Aug; 90(2):227-34. PubMed ID: 21726903
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of gonadotropin-releasing hormone agonist treatment for prevention of menstrual-related attacks in acute porphyria.
Innala E; Bäckström T; Bixo M; Andersson C
Acta Obstet Gynecol Scand; 2010; 89(1):95-100. PubMed ID: 20021268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
